|Articles|April 15, 2020

Contagion Live News Network: Coronavirus Updates for April 15, 2020

Stay up to date on the latest coronavirus updates from April 15th.

Welcome to the Contagion Live News Network, I’m Michaela Fleming and this is your coronavirus update for Wednesday April 15, 2020.

There are now more than 2 million cases of COVID-19 worldwide. Six hundred thousand of those cases are in the United States.

According to Johns Hopkin, there have been more than 3.1 million tests performed in the United States. The largest number of tests have been conducted in New York, with nearly 500,000 tests performed.

Be sure to check out Contagion®’s listicle on COVID-19 clinical trials that has been adapted from clinicaltrials.gov.

If you missed our COVID-19 From the Frontlines webinar, you can read a recap and also re-watch the program.

Contagion® also covered the emergency use authorization of a saliva test for SARS-CoV-2 which was developed by investigators at Rutgers University.

Today’s new COVID-19 articles also zero in on medication shortages that are occurring across the United States and a detailed review of where supplies from the Strategic National Stockpile are being disseminated. We also have featured new interviews with Dr. Ramy Elshaboury from Massachusetts General Hospital and Dr. Paul Blair from Johns Hopkins.

For other stories relevant to COVID-19 and the latest infectious disease news, visit ContagionLive.com. To track the spread of the pandemic in the United States and abroad, be sure to use the Contagion® Outbreak Monitor.

For the Contagion Live News Network, I’m Michaela Fleming, thanks for tuning in.


Related to this article

New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
Measles Update: October 2, 2026
The latest CDC numbers show a 6.2% increase of measles cases from week-to-week. Last week there was a 5.4% increase in cases showing a continuing steady increase dictated by ongoing outbreaks across the US.